How we drive change
The Foundation has been working to stimulate and guide the pharmaceutical industry to do more for people living in low- and middle-income countries for more than ten years. Find out more about our three-part model for change.
3-part model for change
Our mission is to stimulate and guide pharmaceutical companies to do more for the people who live in low- and middle-income countries. To achieve this mission, we use a three-part model for change that takes our research as its starting point.
1. Build stakeholder consensus
We build consensus on where pharmaceutical companies can and should be taking action to improve access to medicine. Every two years, we translate the stakeholder consensus into clear metrics for measuring company behaviour. The Foundation was the first organisation to determine the path for pharma companies to follow.
2. Stimulate pharma companies to compete on priority health topics
Our research identifies the best performers on access to medicine. By publicly recognising companies’ positive actions, we trigger other companies to join a “race to do well” on priority health targets and topics.
